Medicus Pharma Ltd. (MDCX)
2.50
-0.12
(-4.58%)
USD |
NASDAQ |
Oct 23, 16:00
2.58
+0.08
(+3.20%)
After-Hours: 20:00
Medicus Pharma EPS Diluted (Quarterly) : -0.1524 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1524 |
| March 31, 2026 | -0.2231 |
| December 31, 2025 | -0.4292 |
| September 30, 2025 | -0.816 |
| June 30, 2025 | -0.3122 |
| March 31, 2025 | -0.2905 |
| December 31, 2024 | -0.1376 |
| September 30, 2024 | -8.780 |
| June 30, 2024 | -16.26 |
| Date | Value |
|---|---|
| March 31, 2024 | -7.838 |
| December 31, 2023 | -0.2311 |
| September 30, 2023 | -0.2737 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.0294 |
| September 30, 2022 | -0.1575 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 0.2802 |
| enGene Therapeutics, Inc. | -0.4661 |
| Xenon Pharmaceuticals, Inc. | -1.112 |
| Psyence Biomedical Ltd. | -3.178 |
| AVITA Medical, Inc. | -0.2492 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.440M |
| Total Expenses (Quarterly) | 8.392M |
| Enterprise Value | 155.00M |
| Earnings Yield | -64.83% |
| Normalized Earnings Yield | -54.51 |